Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
SICKLE CELL, THROMBOSIS, AND CLASSICAL HAEMATOLOGY
RESEARCH ARTICLE
Open Access
oa
Genotype-phenotype associations in individuals with Diamond Blackfan anaemia
- Pages: 1117-1124
- First Published: 16 October 2024
Open Access
oa
Isolated thrombocytopenia in pregnancy: A monocentric retrospective study of 63 pregnancies in 59 women
- Pages: 1125-1132
- First Published: 08 November 2024
HAEMATOLOGIC MALIGNANCY - PLASMA CELL
RESEARCH ARTICLE
Open Access
oa
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health Service
- Pages: 1133-1143
- First Published: 25 October 2024
Open Access
oa
The evolving treatment landscape of multiple myeloma in Portugal: A nation-wide retrospective cohort study of real-world clinical practice
- Pages: 1144-1153
- First Published: 28 October 2024
Open Access
oa
Real-world practitioner perceptions of CARTITUDE-4 results for patients with previously treated multiple myeloma
- Pages: 1154-1164
- First Published: 25 November 2024
HAEMATOLOGIC MALIGNANCY - LYMPHOID
RESEARCH ARTICLE
Open Access
oa
Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL-specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma
- Pages: 1165-1172
- First Published: 07 October 2024
Open Access
oa
A phase 2 study of frontline pembrolizumab in follicular lymphoma
- Pages: 1173-1181
- First Published: 10 October 2024
Open Access
oa
Interleukin-6 transcripts up-regulation in lymph nodes from unicentric and multicentric Castleman disease
- Pages: 1182-1189
- First Published: 23 October 2024
Open Access
oa
Congestive heart failure after anthracycline-containing treatment for Hodgkin lymphoma: A Swedish matched cohort study
- Pages: 1190-1200
- First Published: 13 November 2024
Open Access
oa
Association between microenvironment-related genes and prognosis of primary central nervous system lymphoma
- Pages: 1201-1214
- First Published: 14 November 2024
Open Access
oa
Enteropathy-associated T-cell lymphoma: A population-based cohort study on incidence, treatment, and outcome in the Netherlands
- Pages: 1215-1222
- First Published: 29 November 2024
HAEMATOLOGIC MALIGNANCY - MYELOID
RESEARCH ARTICLE
Open Access
oa
The prognostic impact of C-reactive protein and albumin in patients diagnosed with acute myeloid leukaemia
- Pages: 1223-1235
- First Published: 17 October 2024
Open Access
oa
Optimization criteria for ordering myeloid neoplasm next-generation sequencing
- Pages: 1236-1242
- First Published: 23 October 2024
Open Access
oa
Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report
- Pages: 1243-1251
- First Published: 25 October 2024
STEM CELL TRANSPLANTATION & CELLULAR THERAPY
RESEARCH ARTICLE
Open Access
oa
Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses
- Pages: 1252-1259
- First Published: 04 November 2024
SHORT REPORT
Open Access
oa
Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myeloma
- Pages: 1260-1264
- First Published: 20 October 2024
Open Access
oa
Emergence of IGH::CCND1 rearrangement and mutations in TP53, BTK, and BCL2 associated with therapy resistance in chronic lymphocytic leukemia
- Pages: 1265-1268
- First Published: 08 October 2024
Open Access
oa
Extramedullary disease in Waldenström macroglobulinemia: A population-based observational study
- Pages: 1269-1273
- First Published: 25 October 2024
Open Access
oa
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practice
- Pages: 1274-1277
- First Published: 22 November 2024
Open Access
oa
IFN-α treatment may enable discontinuation of TKIs in NK cell-licensed patients with CML-CP
- Pages: 1278-1282
- First Published: 26 November 2024
Open Access
oa
CD19-targeting chimeric antigen receptor T-cell therapy is safe and effective for intra-cardiac B cell non-Hodgkin lymphoma
- Pages: 1283-1289
- First Published: 17 October 2024
Open Access
oa
Oral acute graft-versus-host disease
- Pages: 1290-1294
- First Published: 20 October 2024
Open Access
oa
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
- Pages: 1295-1300
- First Published: 26 November 2024
REVIEW
Open Access
oa
New insights into the mechanisms of red blood cell enucleation: From basics to clinical applications
- Pages: 1301-1311
- First Published: 13 November 2024
Open Access
oa
Safety and efficacy of ketamine use in patients with vaso-occlusive crisis: A systematic review and meta-analysis
- Pages: 1312-1321
- First Published: 25 November 2024
CASE REPORT
Open Access
oa
Shrimp allergy leading to severe transfusion reaction: A case report
- Pages: 1322-1324
- First Published: 07 October 2024
Open Access
oa
Dosing strategy of intrapleural bortezomib for myelomatous pleural effusion: A case report and review of literature
- Pages: 1325-1329
- First Published: 10 October 2024
Open Access
oa
RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis
- Pages: 1330-1334
- First Published: 29 October 2024
Open Access
oa
Successful treatment of low-risk myelodysplastic syndrome-related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
- Pages: 1335-1339
- First Published: 25 November 2024
HAEMATOLOGY IMAGES
Open Access
oa
Hepatic T cell lymphoma after chimeric antigen receptor T cell therapy for myeloma
- Pages: 1340-1341
- First Published: 10 October 2024
Open Access
oa
A panoply of neoplastic plasma cells
- Pages: 1342-1343
- First Published: 24 October 2024
Open Access
oa
Pitfalls on 18-fluorodeoxyglucose positron emission tomography-computed tomography: Immunoglobulin G4-related lymphadenopathy
- Pages: 1344-1345
- First Published: 11 October 2024
Open Access
oa
Metabolic pitfall of pseudoprogression after epcoritamab treatment
- Pages: 1346-1347
- First Published: 16 October 2024
Open Access
oa
Cyclin D1-negative and SOX11-positive B-cell lymphoma with CD5 and CD10 coexpression and MYC rearrangement: A diagnostic challenge
- Pages: 1348-1350
- First Published: 20 October 2024
Open Access
oa
Terminal deoxynucleotidyl transferase-positive high-grade B-cell lymphoma with MYC and BCL2 rearrangements transformed from follicular lymphoma
- Pages: 1351-1353
- First Published: 02 December 2024
CORRESPONDENCE
Open Access
oa
Luspatercept in β-thalassemia: Who and when. Strengths and weaknesses points of a real-world evidence
- Pages: 1354-1358
- First Published: 04 November 2024
Open Access
oa
Immediate improvement in patient care: Auditing adherence to the British Society for Haematology guidelines on screening and management of the long-term consequences of multiple myeloma and treatment
- Pages: 1359-1362
- First Published: 15 November 2024
Open Access
oa
Low-dose nivolumab for extranodal natural killer/T-cell lymphoma, nasal type
- Pages: 1363-1365
- First Published: 29 November 2024
Open Access
oa
Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients
- Pages: 1366-1369
- First Published: 07 October 2024
Open Access
oa
Impact of secondary-type mutations in acute myeloid leukemia with CEBPA mutation
- Pages: 1370-1372
- First Published: 22 November 2024
CORRIGENDUM
Open Access
oa
Correction to: Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG-PET/CT
- Page: 1373
- First Published: 04 November 2024